Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Assets: 2017-2024

Historic Other Non-Current Assets for Protagonist Therapeutics (PTGX) over the last 8 years, with Dec 2024 value amounting to $225,000.

  • Protagonist Therapeutics' Other Non-Current Assets rose 27.56% to $287,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $287,000, marking a year-over-year increase of 27.56%. This contributed to the annual value of $225,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Protagonist Therapeutics' Other Non-Current Assets is $225,000, which was down 0.00% from $225,000 recorded in FY2023.
  • Protagonist Therapeutics' Other Non-Current Assets' 5-year high stood at $450,000 during FY2020, with a 5-year trough of $225,000 in FY2021.
  • For the 3-year period, Protagonist Therapeutics' Other Non-Current Assets averaged around $225,000, with its median value being $225,000 (2024).
  • Data for Protagonist Therapeutics' Other Non-Current Assets shows a maximum YoY crashed of 50.00% (in 2021) over the last 5 years.
  • Protagonist Therapeutics' Other Non-Current Assets (Yearly) stood at $450,000 in 2020, then tumbled by 50.00% to $225,000 in 2021, then remained steady at $225,000 in 2022, then remained steady at $225,000 in 2023, then remained steady at $225,000 in 2024.